Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.300
0.00 (0.00%)
Oct 16, 2026, 4:00 PM EST
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $62.96 million as of October 19, 2026. It is the 28,595th most valuable company in the world and the 4,474th biggest in the United States. Its market cap has decreased by 45.21% in one year.
Market Cap
62.96M
Enterprise Value
64.32M
Revenue
5.20M
Global Rank
Country Rank
#4,474 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 62.96M, an increase of 217.13%. That is a compound annual growth rate of 12.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 62.96M | -33.66% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 110.10M |
| BetterLife Pharma | 98.39M |
| ProText Mobility | 69.45M |
| NDT Pharmaceuticals | 63.05M |
| Sangamo Therapeutics | 45.65M |
| Arch Biopartners | 38.76M |
| Biomind Labs | 35.68M |
| Cell Source | 33.63M |